Close Menu

NEW YORK – Biodesix today priced its initial public offering of 4 million shares of its common stock at $18 per share for anticipated gross proceeds of $72 million.

Shares of the Boulder, Colorado-based firm will begin trading on the Nasdaq today under ticker symbol "BDSX".

Biodesix is also granting the IPO underwriters a 30-day option to purchase an additional 600,000 shares at the offering price, which would raise an additional $10.8 million. The firm expects the offering to close on Oct. 30.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.